Global Stem Cell Therapy Market Research Report, by Type (Allogeneic, Autologous), by Product Type (Antibodies, Kits), by Application (Clinical Research), & by End-User (Clinical Diagnostics, Hospitals & Research Institutes) – Global Forecast Till 2023

Market Scenario

The global stem cell therapy market is expected to reach an approximate CAGR of 10.3% during the forecast period. The use of stem cell for treating medical conditions is referred to as stem cell therapy. Stem cells are undifferentiated cells and differentiate into specialized cell types. This ability of stem cells to differentiate into cells of interest is used to treat diseases like diabetes, heart disease, hematopoietic disorders (for example leukemia, thalassemia, and others), degenerative disorders (osteoarthritis, Alzheimer’s disease, Parkinson’s disease, chronic renal failure, congestive cardiac failure,) and others.

Key factors responsible for the market growth are the rising awareness for therapeutic application of stem cells in disease management, rising research for stem cell therapy applications, development of advanced genetic analysis techniques, increasing public-private investments for stem cell research, growing research in identification of new stem cell lines, and new developments in stem cell banking infrastructure are driving the growth of the global stem cell therapy market. Stem cells are used in the treatment of Alzheimer’s by replacing the diseased cells with stem cells. This approach has great potential in preventing or halting several neurodegenerative diseases like Alzheimer’s. According to the Alzheimer’s Association in 2018, 5.7 million Americans are affected by Alzheimer’s disease. Thus, such a high incidence of neurological diseases and increasing government funding enhances the growth in this market.

However, factors such as, difficulty in collection and storage procedures of somatic stem cells, chances of cross contaminations, shortage of skilled labor expensive procedures and regulatory complications are expected to restrict the market growth during the forecast period.

Segmentation

The global stem cell therapy market is segmented on the basis of type, therapeutic application, cell source, and end-user. The stem cell therapy market, by type, is sub-segmented into Allogeneic and Autologous.

On the basis of therapeutic application, the market is categorized into medicine, cardiovascular diseases, bone regeneration, neurodegenerative disorders, wound healing, treatment of eyes, hematopoietic disorders, metabolic disorders, cancer, immunodeficiency, and diabetes. Cell source is further sub-segmented into adipose tissue, bone marrow, neural, embryo/cord blood-derived, iPSCs. On the basis of end-user, the market is segmented into biotechnology companies, hospitals & research institutes, contract research organizations and stem cell banks.

On the basis of region, the global stem cell therapy market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players

Some of the key players are Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (US), RTI Surgical, Inc. (US), and AlloSource (US), Thermo Fisher Scientific are some of the key players operating in the global stem cell therapy market.

The stem cell therapy market is dominated by North America owing to the high prevalence of chronic diseases and high R&D investments within this region stimulate market growth. According to the US Investments in Medical and Health Research and Development in 2016, the United States invested total USD171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of diseases drives the market growth in this region.

It is estimated that Europe stood second in the global stem cell therapy market. Rising prevalence of chronic diseases such as cancer is driving the growth of this market in Europe. According to the Eurostat in 2014, 272 thousand people deaths were due to lung cancer. Thus, increasing prevalence of cancer in Europe drives the market growth. Furthermore, the rapidly growing biotechnology sector in Europe is expected to boost the market in this region.

Asia-Pacific was projected to be the fastest growing region for the global stem cell therapy market. Key factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector influences the market in this region. Also, the presence of major market players in China, India, and Japan drives the market growth.

The Middle East and Africa holds the least share in the global stem cell therapy market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.

Market Segmentation

Global Stem Cell Therapy Market, by Technique,

Primary (Direct) Stem Cell Therapy
Secondary (Indirect) Stem Cell Therapy
Salt split technique
Antigenic mapping method
Double staining method
Micro Immunofluorescence

Global Stem Cell Therapy Market, by Product Type

Antibodies
Kits and reagents
Instruments
Microscopes
Imaging Analysis Systems
Labeling dyes
Species Product Type

Global Stem Cell Therapy Market, by Application

Clinical research
Clinical Diagnostics
Infectious Diseases
Cancer
Cardiovascular Diseases
Autoimmune Diseases
Neurological Diseases
Research & Development

Global Stem Cell Therapy Market, by End-User

Biotechnology Companies
Hospitals & Research Institutes
Contract Research Organizations
Diagnostic centers

Global Stem Cell Therapy Market, by Region

Americas
Europe
Asia-Pacific
Middle East & Africa

Global Stem Cell Therapy Market, by Key Players

Abcam plc
Thermo Fisher Scientific
BioLegend, Inc.
Enzo Life Sciences, Inc.
Sino Biological Inc.
BioTek Instruments, Inc.
Bio-Rad Laboratories, Inc.
Zyagen
Cell Signaling Technology, Inc.
PerkinElmer Inc.
Becton Dickinson and Company
Merck
Agilent Technologies
TCS Biosciences Ltd
Maxvision Biosciences Inc.
Others

Intended Audience

Pharmaceutical companies
Biotechnological institutes
Government and private laboratories
Research and Development (R&D) companies
Medical research laboratories
Market research and consulting service providers